Evidence map›Paper›PMID 41060251›Full record

ArticleCritical care explorations2025

Aging and Host Responses to Severe Infection: Proteomic Analysis of a Prospective Multicenter Cohort From Uganda.

Gabriel Conte Cortez Martins, Julius J Lutwama, Nicholas Owor, Alin S Tomoiaga, Jesse E Ross, Xuan Lu, Christopher Nsereko, Irene Nayiga, Stephen Kyebambe, Joseph Shinyale and 19 more

Abstract readMulticenter Study
In one paragraph

Article in Critical care explorations, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Gabriel Conte Cortez MartinsDepartment of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY.ORCID 0000-0001-5175-6076
Julius J LutwamaDepartment of Arbovirology, Emerging and Re-emerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda.
Nicholas OworDepartment of Arbovirology, Emerging and Re-emerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda.
Alin S TomoiagaDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY.
Jesse E RossDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY.
Xuan LuDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY.
Christopher NserekoEntebbe Regional Referral Hospital, Ministry of Health, Entebbe, Uganda.
Irene NayigaEntebbe Regional Referral Hospital, Ministry of Health, Entebbe, Uganda.
Stephen KyebambeEntebbe Regional Referral Hospital, Ministry of Health, Entebbe, Uganda.
Joseph ShinyaleEntebbe Regional Referral Hospital, Ministry of Health, Entebbe, Uganda.
Thomas OcharTororo General Hospital, Ministry of Health, Tororo, Uganda.
Moses KiwubeyiTororo General Hospital, Ministry of Health, Tororo, Uganda.
Rittah NankwangaTororo General Hospital, Ministry of Health, Tororo, Uganda.
Kai NieHuman Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY.
Hui XieHuman Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY.
Sam Miake-LyeHuman Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY.
Bryan VillagomezHuman Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY.
Jingjing QiHuman Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY.
Steven J ReynoldsDivision of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
Martina Cathy NakibuukaRakai Health Sciences Program, Kalisizo, Uganda.
John KayiwaDepartment of Arbovirology, Emerging and Re-emerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda.
Mercy HaumbaDepartment of Arbovirology, Emerging and Re-emerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda.
Joweria NakaseeguDepartment of Arbovirology, Emerging and Re-emerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda.
Xiaoyu CheDepartment of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY.
Seunghee Kim-SchulzeHuman Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY.
W Ian LipkinCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY.
Max R O'DonnellDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY.
Barnabas BakamutumahoDepartment of Arbovirology, Emerging and Re-emerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda.
Matthew J CummingsDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY.

Funding

Multidimensional and longitudinal immune profiling of sepsis in UgandaR01AI184997 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Matthew John Cummings · 2024 to 2026
$2.0M
Mentoring Multidisciplinary Research in MDR-TB Adherence and the Emergent Drug ResistanceK24AI191996 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Max O'Donnell · 2025 to 2026
$419k
NIAID NIH HHS K24 AI191996NIAID NIH HHS R01 AI184997
6 · The paper itself

Abstract

objectiveSevere infectious diseases are a leading cause of morbidity and mortality worldwide, particularly in sub-Saharan Africa (SSA), where young and middle-aged adults are disproportionately affected. Although age-related immune changes such as inflammaging and immunosenescence have been well characterized in high-income countries, their relevance to host responses during infection in SSA remains poorly understood. We aimed to characterize age-associated differences in immune, metabolic, and endothelial responses to severe infection in a prospective, multicenter cohort of adults in Uganda.

designProspective cohort study.

settingTwo public referral hospitals in Uganda. PATIENTS: Non-pregnant adults (18 yr old or older) hospitalized with severe, undifferentiated infection.

interventionsNone. MEASUREMENTS AND MAIN

resultsWe analyzed clinical data and serum Olink proteomic profiles from 434 participants (median age: 45 yr old, interquartile range : 31-57). Clinically, illness severity and mortality were highest and comparable among adults 35-44, 45-59, and 60 years old or older, relative to younger adults. HIV prevalence peaked in the 35-44 and 45-59 age groups. Although most host responses were conserved across age groups after adjustment for sex and high-burden co-infections, patients 60 years old or older exhibited distinct immune dysregulation characterized by signs of Th1-predominant innate immune activation (increased CXCL9, CCL18, MCP1, and MCP4 expression, reduced interleukin-13 expression), dysregulated adaptive immunity (increased soluble CD27 and CD70 expression, reduced CD21 [CR2] expression), and increased cellular turnover and endothelial remodeling.

conclusionsOlder age (60 yr old or older) is associated with distinct host responses to severe infection in SSA. These findings may inform development of age-stratified, host-directed treatment strategies for severe infectious diseases.

Indexed as

AgingProteomicsAdultAge FactorsFemaleHIV InfectionsHumansMaleMiddle AgedProspective StudiesSeverity of Illness IndexUgandaAfricaagingimmunologyinfectionproteomics

Identifiers

PMID41060251
PMCPMC12506988

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.